Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Solexa Shareholders to Vote on Acquisition Details Jan. 26

NEW YORK (GenomeWeb News) — Illumina and Solexa shareholders will meet independently on Jan. 26, 2007 to vote on aspects of Illumina’s $600 million bid to acquire Solexa, Illumina said today.
 
Solexa shareholders will meet to consider and vote on the deal, while Illumina stockholders will meet to consider issuing Illumina shares to Solexa stockholders.
The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.